Article
Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study.
Department of Radiology, University of Groningen, University Medical Center Groningen, EB44, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.
European Radiology (impact factor:
3.22).
07/2012;
DOI:10.1007/s00330-012-2570-7
Source: PubMed
- Citations (25)
-
Cited In (0)
-
Article: Correction: Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000
[show abstract] [hide abstract]
ABSTRACT: After the publication of this work [1], we noticed the typographical errors in Tables 8, 9, 16, and 17: there were inconsistencies between the ranking of cancer mortality and incidence and their corresponding figures. Here we briefly present the results along with the revisions of the relevant tables since the ranking was corrected while the figures remained the same as the original. -
Article: Investigating the low-dose limits of multidetector CT in lung nodule surveillance.
[show abstract] [hide abstract]
ABSTRACT: The purpose of this study was to evaluate the factors limiting nodule detection in thoracic computed tomography (CT) and to determine whether prior knowledge of nodule size and attenuation, available from a baseline CT study, influences the minimum radiation dose at which nodule surveillance CT scans can be performed while maintaining current levels of nodule detectability. Multiple nodules varying in attenuation (-509 to + 110 HU) and diameter (1.6 to 9.5 mm) were layered in random and ordered sequences within 2 lung cylinders made of Rando lung material and suspended within a custom-built CT phantom. Multiple CT scans were performed at varying kVp (120, 100, and 80), mA (200, 150, 100, 50, 20, and 10), and beam collimation (5, 2.5, and 1.25 mm) on a four-row multidetector scanner (Lightspeed, General Electric, Milwaukee, WI) using 0.8 s gantry rotation. The corresponding range of radiation dose over which images were acquired was 0.3-26.4 mGy. Nine observers independently performed three specific tasks, namely: (1) To detect a 3.2 mm nodule of 23 HU; (2) To detect 3.2 mm nodules of varying attenuation (-509 to -154 HU); and (3) To detect nodules varying in size (1.6-9 mm) and attenuation (-509 to 110 HU). A two-alternative forced-choice test was used in order to determine the limits of nodule detection in terms of the proportion of correct responses (Pcorr, related to the area under the ROC curve) as a summary metric of observer performance. The radiation dose levels for detection of 99% of nodules in each task were as follows: Task 1 (1 mGy); Task 2 (5 mGy); and Task 3 (7 mGy). The corresponding interobserver confidence limits were 1, 5, and 10 mGy for Tasks 1, 2, and 3, respectively. There was a fivefold increase in the radiation dose required for detection of lower-density nodules (Tasks 1 to 2). Absence of prior knowledge of the nodule size and density (Task 3) corresponds to a significant increase in the minimum required radiation dose. Significant image degradation and reduction in observer performance for all tasks occur at a dose of < or = 1 mGy. It is concluded that the size and attenuation of a nodule strongly influence the radiation dose required for confident evaluation with a minimum threshold value of 1-2 mGy (minimum dose CT). A prior knowledge of nodule size and attenuation is available from the baseline CT scan and is an important consideration in minimizing the radiation exposure required for nodule detection with surveillance CT.Medical Physics 09/2007; 34(9):3587-95. · 2.83 Impact Factor -
Article: Preclinical multimodality phantom design for quality assurance of tumor size measurement.
[show abstract] [hide abstract]
ABSTRACT: ABSTRACT: Evaluation of changes in tumor size from images acquired by ultrasound (US), computed tomography (CT) or magnetic resonance imaging (MRI) is a common measure of cancer chemotherapy efficacy. Tumor size measurement based on either the World Health Organization (WHO) criteria or the Response Evaluation Criteria in Solid Tumors (RECIST) is the only imaging biomarker for anti-cancer drug testing presently approved by the United States Food and Drug Administration (FDA). The aim of this paper was to design and test a quality assurance phantom with the capability of monitoring tumor size changes with multiple preclinical imaging scanners (US, CT and MRI) in order to facilitate preclinical anti-cancer drug testing. Three phantoms (Gammex/UTHSCSA Mark 1, Gammex/UTHSCSA Mark 2 and UTHSCSA multimodality tumor measurement phantom) containing tumor-simulating test objects were designed and constructed. All three phantoms were scanned in US, CT and MRI devices. The size of test objects in the phantoms was measured from the US, CT and MRI images. RECIST, WHO and volume analyses were performed. The smaller phantom size, simplified design and better test object CT contrast of the UTHSCSA multimodality tumor measurement phantom allowed scanning of the phantom in preclinical US, CT and MRI scanners compared with only limited preclinical scanning capability of Mark 1 and Mark 2 phantoms. For all imaging modalities, RECIST and WHO errors were reduced for UTHSCSA multimodality tumor measurement phantom (≤1.69 ± 0.33%) compared with both Mark 1 (≤ -7.56 ± 6.52%) and Mark 2 (≤ 5.66 ± 1.41%) phantoms. For the UTHSCSA multimodality tumor measurement phantom, measured tumor volumes were highly correlated with NIST traceable design volumes for US (R2 = 1.000, p < 0.0001), CT (R2 = 0.9999, p < 0.0001) and MRI (R2 = 0.9998, p < 0.0001). The UTHSCSA multimodality tumor measurement phantom described in this study can potentially be a useful quality assurance tool for verifying radiologic assessment of tumor size change during preclinical anti-cancer therapy testing with multiple imaging modalities.BMC Medical Physics 09/2011; 11:1.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
64-row multidetector CT
accurate nodule volumes
anthropomorphic thoracic phantom
artificial pulmonary nodules
artificial spherical nodules
detecting spherical pulmonary nodules
diameter 3
false-positive nodules
inter-technique correlation
KEY POINTS
low-dose CT
low-dose protocol
manual measurement
Nodule diameter
non-solid 3-mm nodules
pulmonary nodules
semi-automated method
semi-automated quantification
solid nodules
• Low-dose CT